Clinical Trial Update: KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of ferric citrate (KRX-0502) for treating iron deficiency anemia in adults with non-dialysis-dependent chronic kidney disease has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• Ferric citrate (ferric citrate)

Snippet

Sponsor: Keryx Biopharmaceuticals | Conditions: Anemia of Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2018-02-22